Though total same-store sales were down 8%, Walgreens Friday morning characterized a first quarter lifted by a steady influx of returning Express Scripts patients and driven by a steady stream of new Balance Rewards members.
Rite Aid beat analyst expectations in third quarter 2013 as the generic wave and retention of Express Scripts customers helped drive better-than-expected adjusted EBIDTA and produced the company's first profitable quarter in five years.
Misfit Wearables is teeing up a revolutionary activity tracking device — the Misfit Shine — that's constructed from aircraft-grade aluminum, is waterproof and is able to wirelessly sync activity data to a smartphone without the need for a Bluetooth connection.
The influenza season is officially underway as flu incidence is already above the national threshold, Thomas Frieden, director of the Centers for Disease Control and Prevention, told reporters during a teleconference Monday.
Westport Pharmaceuticals on Tuesday launched Zephrex-D, a tamper-resistant pseudoephedrine-based decongestant that is now available in retail stores throughout the St. Louis region and the state of Missouri.
Di-Gel Products on Friday announced a "Di-Gel Comfort Zone" with complementary, clean restrooms will be established in downtown Manhattan the day after Thanksgiving to help alleviate some of the discomfort from Thanksgiving meals the day before and the long retail lines associated with Black Friday.
The battle for Schiff Nutrition is on. Reckitt Benckiser on Friday commenced its previously announced tender offer to acquire all of the outstanding shares of Schiff Nutrition — a provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere — for $42 per share in cash, or approximately $1.4 billion.
The Food and Drug Administration's Nonprescription Drugs Advisory Committee on Friday voted against Merck's application to switch its Oxytrol patch from prescription-only to over the counter, citing concerns over use of therapy for an overactive bladder in women without a doctor's intervention.
A recent WorkPlace Media survey of working consumers found that 3-out-of-4 workers impacted by allergies purchase an allergy-relieving product when symptoms appear, because the normal pattern when allergy symptoms strike is to keep working versus going home sick.
Business for OTC store brands is expected to boom in the coming year, Perrigo chairman and CEO Joseph Papa told analysts discussing the private-label manufacturer's first quarter results during a conference call Wednesday, even as the growth rate across the entire OTC category slows.
Hurricane Sandy may have shut down lower Manhattan for a few days, but research analyst Ed Kelly of Credit Suisse was bullish on how the storm system may have whipped up front-end sales for pharmacy operators.
Progress at re-opening its manufacturing facility in Lincoln, Neb., has been slow-going, Novartis reported Thursday, but the company has contracted third-party manufacturers to resume production of Excedrin, Lamisil and Triaminic.
While Supervalu has completed its overhaul of its value proposition across its Jewel-Osco banner, the grocer will be analyzing the impact before replicating the price repositioning across its entire chain.